Johannes Ottl

Novartis Institutes for BioMedical Research, Chemical Biology & Therapeutics, Chemical Genetics
Nina E. Weisser
Johannes Ottl is Director at the Novartis Institutes of BioMedical Research (NIBR) heading the Encoded Library Technologies group. Current focus of his research includes the investigation of novel innovative pharmaceutical drug discovery approaches and the identification of lead finding starting points with DNA-encoded small molecules libraries (DEL) as well as encoded peptide libraries in the Chemical Biology and Therapeutics / Chemical Genetics department. He received his Ph.D. in Bioorganic Chemistry at the Max Planck Institute of Biochemistry in Martinsried in 1998 and his Chemistry diploma at the Ludwig Maximilians Universitaet in Munich in 1995.?After his PhD he worked as PostDoc at Novartis Pharmaceutical Research in Basel on radio-tag encoded combinatorial library synthesis. In 2000 he started his pharmaceutical industry career in various multidisciplinary drug discovery assignments focussing on highly miniaturized fully automated confocal microscopy based screening, lead finding, biophysics, and collaborations with BioTech partners around encoded library technologies.


No data was found